Gene: GOT2
Official Full Name: glutamic-oxaloacetic transaminase 2provided by HGNC
Gene Summary: Glutamic-oxaloacetic transaminase is a pyridoxal phosphate-dependent enzyme which exists in cytoplasmic and inner-membrane mitochondrial forms, GOT1 and GOT2, respectively. GOT plays a role in amino acid metabolism and the urea and tricarboxylic acid cycles. The two enzymes are homodimeric and show close homology. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2013]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO07194 | GOT2 Knockout cell line (HeLa) | Human | GOT2 | 1:3~1:6 | Negative | Online Inquiry |
KO07195 | GOT2 Knockout cell line (HCT 116) | Human | GOT2 | 1:2~1:4 | Negative | Online Inquiry |
KO07196 | GOT2 Knockout cell line (HEK293) | Human | GOT2 | 1:3~1:6 | Negative | Online Inquiry |
KO07197 | GOT2 Knockout cell line (A549) | Human | GOT2 | 1:3~1:4 | Negative | Online Inquiry |
GOT2 Gene Knockout Cell Lines are a specialized model system designed for the investigation of glutamate oxaloacetate transaminase 2 (GOT2) function in cellular physiology and disease. These genetically modified cell lines are characterized by the specific deletion of the GOT2 gene, which encodes a key enzyme involved in amino acid and carbohydrate metabolism. The knockout mechanism typically employs CRISPR-Cas9 technology, ensuring precise removal of the gene, which leads to the disruption of mitochondrial aspartate synthesis and subsequently affects the cellular metabolic balance.
The primary function of GOT2 involves the transamination process that plays a critical role in the tricarboxylic acid cycle and nitrogen metabolism. By utilizing this knockout model, researchers can precisely analyze the genetic and biochemical implications of loss of GOT2 function, aiding in the understanding of metabolic disorders, mitochondrial dysfunctions, and cancer metabolism. Furthermore, these cell lines provide a valuable platform for therapeutic research, including drug screening and biomarker development.
What sets our GOT2 Gene Knockout Cell Lines apart from traditional models is their unparalleled specificity and sensitivity, providing researchers with a powerful tool to dissect metabolic pathways with greater accuracy. The ability to examine the consequences of GOT2 deletion in cellular environments mirrors physiological conditions more closely than transient knockdown models, enhancing the reproducibility and reliability of experimental results.
These cell lines hold significant promise for elucidating the role of GOT2 in various diseases, thereby serving as a critical asset for both academic and clinical researchers seeking to innovate in biomedical sciences. Our commitment to advancing research quality is underpinned by rigorous quality control measures and comprehensive support for users, further affirming our position as a leader in the provision of biological products. With GOT2 Gene Knockout Cell Lines, you will be equipped to uncover new insights into metabolic regulation and therapeutic interventions.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.